Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional penetrating corneal transplantation

Progress in Retinal and Eye Research - Tập 73 - Trang 100768 - 2019
Deniz Hos1,2, Mario Matthaei1, Felix Bock1,2, Kazuichi Maruyama3, Maria Notara1,2, Thomas Clahsen1, Yanhong Hou1, Viet Nhat Hung Le1,4, Ann-Charlott Salabarria1, Jens Horstmann1, Bjoern O. Bachmann1, Claus Cursiefen1,2
1Department of Ophthalmology, University of Cologne, Cologne, Germany
2Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
3Department of Innovative Visual Science, Graduate School of Medicine, Osaka University, Japan
4Department of Ophthalmology, Hue College of Medicine and Pharmacy, Hue University, Viet Nam

Tài liệu tham khảo

Abdelfattah, 2016, Molecular underpinnings of corneal angiogenesis: advances over the past decade, Int. J. Ophthalmol., 9, 768 Abell, 2014, Effect of femtosecond laser-assisted cataract surgery on the corneal endothelium, J. Cataract Refract. Surg., 40, 1777, 10.1016/j.jcrs.2014.05.031 Abud, 2017, Systemic immunomodulatory strategies in high-risk corneal transplantation, J. Ophthalmic Vis. Res., 12, 81, 10.4103/2008-322X.200156 Achen, 1998, Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4), Proc. Natl. Acad. Sci. U. S. A, 95, 548, 10.1073/pnas.95.2.548 Aerts-Toegaert, 2007, CD83 expression on dendritic cells and T cells: correlation with effective immune responses, Eur. J. Immunol., 37, 686, 10.1002/eji.200636535 Ahmad, 2016, Boston type 1 keratoprosthesis versus repeat donor keratoplasty for corneal graft failure: a systematic review and meta-analysis, Ophthalmology, 123, 165, 10.1016/j.ophtha.2015.09.028 Albuquerque, 2009, Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth, Nat. Med., 15, 1023, 10.1038/nm.2018 Alitalo, 2005, Lymphangiogenesis in development and human disease, Nature, 438, 946, 10.1038/nature04480 Allan, 2007, Corneal transplant rejection rate and severity after endothelial keratoplasty, Cornea, 26, 1039, 10.1097/ICO.0b013e31812f66e5 Alldredge, 1981, Clinical types of corneal transplant rejection. Their manifestations, frequency, preoperative correlates, and treatment, Arch. Ophthalmol., 99, 599, 10.1001/archopht.1981.03930010599002 Alqudah, 2013, Immediate endothelial cell loss after penetrating keratoplasty, Cornea, 32, 1587, 10.1097/ICO.0b013e3182a73822 Amadio, 2016, Targeting VEGF in eye neovascularization: what's new?: a comprehensive review on current therapies and oligonucleotide-based interventions under development, Pharmacol. Res., 103, 253, 10.1016/j.phrs.2015.11.027 Ambati, 2006, Corneal avascularity is due to soluble VEGF receptor-1, Nature, 443, 993, 10.1038/nature05249 Amescua, 2008, Effect of CXCL-1/KC production in high risk vascularized corneal allografts on T cell recruitment and graft rejection, Transplantation, 85, 615, 10.1097/TP.0b013e3181636d9d Amouzegar, 2016, Alloimmunity and tolerance in corneal transplantation, J. Immunol., 196, 3983, 10.4049/jimmunol.1600251 Andrieu-Soler, 2005, Downregulation of IRS-1 expression causes inhibition of corneal angiogenesis, Investig. Ophthalmol. Vis. Sci., 46, 4072, 10.1167/iovs.05-0105 Ang, 2016, Five-year graft survival comparing descemet stripping automated endothelial keratoplasty and penetrating keratoplasty, Ophthalmology, 123, 1646, 10.1016/j.ophtha.2016.04.049 Anshu, 2011, Descemet's stripping endothelial keratoplasty under failed penetrating keratoplasty: visual rehabilitation and graft survival rate, Ophthalmology, 118, 2155, 10.1016/j.ophtha.2011.04.032 Anshu, 2012, Risk of corneal transplant rejection significantly reduced with Descemet's membrane endothelial keratoplasty, Ophthalmology, 119, 536, 10.1016/j.ophtha.2011.09.019 Anwar, 2002, Big-bubble technique to bare Descemet's membrane in anterior lamellar keratoplasty, J. Cataract Refract. Surg., 28, 398, 10.1016/S0886-3350(01)01181-6 Arbelaez, 2014, Long-term follow-up and complications of stripping descemet membrane without placement of graft in eyes with Fuchs endothelial dystrophy, Cornea, 33, 1295, 10.1097/ICO.0000000000000270 Bachmann, 2010, Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis, Ophthalmology, 117, 1300, 10.1016/j.ophtha.2010.01.039 Bachmann, 2008, Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation, Arch. Ophthalmol., 126, 71, 10.1001/archopht.126.1.71 Bachmann, 2009, Transient postoperative vascular endothelial growth factor (VEGF)-neutralisation improves graft survival in corneas with partly regressed inflammatory neovascularisation, Br. J. Ophthalmol., 93, 1075, 10.1136/bjo.2008.145128 Bachmann, 2008, Patientenzufriedenheit nach posteriorer lamellärer Keratoplastik (DSAEK), Klin. Monatsblatter Augenheilkd., 225, 577, 10.1055/s-2008-1027499 Bachmann, 2017, DMEK: probleme vermeiden, erkennen, lösen, Klin. Monatsblatter Augenheilkd., 234, 1354, 10.1055/s-0043-105269 Baluk, 2008, Markers for microscopic imaging of lymphangiogenesis and angiogenesis, Ann. N. Y. Acad. Sci., 1131, 1, 10.1196/annals.1413.001 Baradaran-Rafii, 2010, Midterm outcomes of autologous cultivated limbal stem cell transplantation with or without penetrating keratoplasty, Cornea, 29, 502, 10.1097/ICO.0b013e3181bd9f60 Barbolina, 2008, Membrane type 1-matrix metalloproteinase: substrate diversity in pericellular proteolysis, Semin. Cell Dev. Biol., 19, 24, 10.1016/j.semcdb.2007.06.008 Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 Basu, 2011, Clinical outcomes of penetrating keratoplasty after autologous cultivated limbal epithelial transplantation for ocular surface burns, Am. J. Ophthalmol., 152, 917, 10.1016/j.ajo.2011.05.019 Baydoun, 2016, Evolution of posterior lamellar keratoplasty: PK - DLEK - DSEK/DSAEK - DMEK - DMET, 73 Baydoun, 2015, Endothelial survival after descemet membrane endothelial keratoplasty: effect of surgical indication and graft adherence status, JAMA Ophthalmol., 133, 1277, 10.1001/jamaophthalmol.2015.3064 Baydoun, 2016, 360-Degree scheimpflug imaging to predict allograft rejection after descemet membrane endothelial keratoplasty, Cornea, 35, 1385, 10.1097/ICO.0000000000001007 Baydoun, 2015, Repeat Descemet membrane endothelial keratoplasty after complicated primary Descemet membrane endothelial keratoplasty, Ophthalmology, 122, 8, 10.1016/j.ophtha.2014.07.024 Berchtold, 1999, Cloning, recombinant expression and biochemical characterization of the murine CD83 molecule which is specifically upregulated during dendritic cell maturation, FEBS Lett., 461, 211, 10.1016/S0014-5793(99)01465-9 Bhatti, 2013, Efficacy of sub-conjunctival and topical bevacizumab in high-risk corneal transplant survival, J. Pak. Med. Assoc., 63, 1256 Bhatti, 2013, Efficacy of topical bevacizumab in high-risk corneal transplant survival, Pak J Med Sci, 29, 519, 10.12669/pjms.292.3089 Billingham, 1953, Actively acquired tolerance of foreign cells, Nature, 172, 603, 10.1038/172603a0 Birbal, 2018, Outcomes of hemi-descemet membrane endothelial keratoplasty for Fuchs endothelial corneal dystrophy, Cornea, 37, 854, 10.1097/ICO.0000000000001578 Birnbaum, 2005, Immunosuppression with cyclosporine A and mycophenolate mofetil after penetrating high-risk keratoplasty: a retrospective study, Transplantation, 79, 964, 10.1097/01.TP.0000158022.62059.F2 Birnbaum, 2009, Mycophenolate mofetil (MMF) following penetrating high-risk keratoplasty: long-term results of a prospective, randomised, multicentre study, Eye, 23, 2063, 10.1038/eye.2008.402 Birnbaum, 2006, An open prospective pilot study on the use of rapamycin after penetrating high-risk keratoplasty, Transplantation, 81, 767, 10.1097/01.tp.0000191291.71003.1b Bock, 2013, Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases, Prog. Retin. Eye Res., 34, 89, 10.1016/j.preteyeres.2013.01.001 Bock, 2016, Identification of novel endogenous anti(lymph)angiogenic factors in the aqueous humor, Investig. Ophthalmol. Vis. Sci., 57, 6554, 10.1167/iovs.15-18526 Bock, 2007, Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis, Investig. Ophthalmol. Vis. Sci., 48, 2545, 10.1167/iovs.06-0570 Bock, 2008, Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation, Graefe's Arch. Clin. Exp. Ophthalmol. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol., 246, 115, 10.1007/s00417-007-0683-5 Bohringer, 2018, Rejection prophylaxis in corneal transplant, Deutsches Arzteblatt Int., 115, 259 Boisgerault, 2009, Differential roles of direct and indirect allorecognition pathways in the rejection of skin and corneal transplants, Transplantation, 87, 16, 10.1097/TP.0b013e318191b38b Boisjoly, 1993, Risk factors of corneal graft failure, Ophthalmology, 100, 1728, 10.1016/S0161-6420(93)31409-0 Borderie, 2011, Graft rejection and graft failure after anterior lamellar versus penetrating keratoplasty, Am. J. Ophthalmol., 151, 1024, 10.1016/j.ajo.2011.01.007 Borderie, 2012, Long-term results of deep anterior lamellar versus penetrating keratoplasty, Ophthalmology, 119, 249, 10.1016/j.ophtha.2011.07.057 Borkar, 2016, Treatment of Fuchs endothelial dystrophy by descemet stripping without endothelial keratoplasty, Cornea, 35, 1267, 10.1097/ICO.0000000000000915 Bourne, 2004, Clinical responses of the corneal endothelium, Exp. Eye Res., 78, 561, 10.1016/j.exer.2003.08.002 Bradley, 2002, Rejection and recipient age, Transpl. Immunol., 10, 125, 10.1016/S0966-3274(02)00058-8 Breloer, 2007, CD83 is a regulator of murine B cell function in vivo, Eur. J. Immunol., 37, 634, 10.1002/eji.200636852 Bucher, 2014, Regression of mature lymphatic vessels in the cornea by photodynamic therapy, Br. J. Ophthalmol., 98, 391, 10.1136/bjophthalmol-2013-303887 Bucher, 2015, Spontaneous long-term course of persistent peripheral graft detachments after Descemet's membrane endothelial keratoplasty, Br. J. Ophthalmol., 99, 768, 10.1136/bjophthalmol-2014-305562 Bucher, 2012, Topical Ranibizumab inhibits inflammatory corneal hem- and lymphangiogenesis, Acta Ophthalmol., 92, 143, 10.1111/j.1755-3768.2012.02525.x Bucher, 2013, OSMO-UT-DSAEK" using THIN-C medium, Graefe's Arch. Clin. Exp. Ophthalmol. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol., 251, 2181, 10.1007/s00417-013-2434-0 Buehler, 2013, Semaphorin 3F forms an anti-angiogenic barrier in outer retina, FEBS Lett., 587, 1650, 10.1016/j.febslet.2013.04.008 Busin, 2013, Ultrathin descemet's stripping automated endothelial keratoplasty with the microkeratome double-pass technique: two-year outcomes, Ophthalmology, 120, 1186, 10.1016/j.ophtha.2012.11.030 Bussolino, 1996, Role of soluble mediators in angiogenesis, Eur. J. Cancer, 32A, 2401, 10.1016/S0959-8049(96)00390-5 Buttner, 2018, Tyrosinase is a novel endogenous regulator of developmental and inflammatory lymphangiogenesis, Am. J. Pathol., 189, 440, 10.1016/j.ajpath.2018.10.014 Buzzonetti, 2010, Standardized big-bubble technique in deep anterior lamellar keratoplasty assisted by the femtosecond laser, J. Cataract Refract. Surg., 36, 1631, 10.1016/j.jcrs.2010.08.013 Cernak, 2002, [Treatment of severe caustic injuries of the anterior segment of the eye with limbal stem cell transplantation, penetrating keratoplasty and amnionic membrane transplantation], Ceska a Slov. Oftalmol. : Cas. Ceske Talmologicke Spolecnosti Slovenske Talmologicke spolecnosti, 58, 16 Chatel, 2010, Sirolimus and mycophenolate as combination prophylaxis in corneal transplant recipients at high rejection risk, Am. J. Ophthalmol., 150, 179, 10.1016/j.ajo.2010.03.010 Chen, 2004, Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity, Nat. Med., 10, 813, 10.1038/nm1078 Cheng, 2011, Endothelial cell loss and visual outcome of deep anterior lamellar keratoplasty versus penetrating keratoplasty: a randomized multicenter clinical trial, Ophthalmology, 118, 302, 10.1016/j.ophtha.2010.06.005 Choi, 2014, Factors affecting successful isolation of human corneal endothelial cells for clinical use, Cell Transplant., 23, 845, 10.3727/096368913X664559 Chow, 2015, Long-term outcomes of high-risk keratoplasty in patients receiving systemic immunosuppression, Cornea, 34, 1395, 10.1097/ICO.0000000000000615 Cotsarelis, 1989, Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: implications on epithelial stem cells, Cell, 57, 201, 10.1016/0092-8674(89)90958-6 Covert, 2007, New triple procedure: descemet's stripping and automated endothelial keratoplasty combined with phacoemulsification and intraocular lens implantation, Ophthalmology, 114, 1272, 10.1016/j.ophtha.2006.12.030 Crawford, 2013, A brief history of corneal transplantation: from ancient to modern, Oman J. Ophthalmol., 6, S12, 10.4103/0974-620X.122289 Cursiefen, 2007, Immune privilege and angiogenic privilege of the cornea, Chem. Immunol. Allergy, 92, 50, 10.1159/000099253 Cursiefen, 2009, GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial, Ophthalmology, 116, 1630, 10.1016/j.ophtha.2009.04.016 Cursiefen, 2004, Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival, Investig. Ophthalmol. Vis. Sci., 45, 2666, 10.1167/iovs.03-1380 Cursiefen, 2004, VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment, J. Clin. Investig., 113, 1040, 10.1172/JCI20465 Cursiefen, 2003, Corneal lymphangiogenesis: evidence, mechanisms, and implications for corneal transplant immunology, Cornea, 22, 273, 10.1097/00003226-200304000-00021 Cursiefen, 2006, Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision, Proc. Natl. Acad. Sci. U. S. A, 103, 11405, 10.1073/pnas.0506112103 Cursiefen, 2012, Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable, Br. J. Ophthalmol., 96, 3, 10.1136/bjo.2011.204701 Cursiefen, 2008, [Descemet's stripping with automated endothelial keratoplasty (DSAEK)], Ophthalmologe : Z. Dtsch. Ophthalmol. Ges., 105, 183, 10.1007/s00347-007-1680-0 Cursiefen, 2010, DMEK: posteriore lamelläre Keratoplastiktechnik, Ophthalmologe : Z. Dtsch. Ophthalmol. Ges., 107, 370, 10.1007/s00347-010-2155-2 Cursiefen, 2009, [Descemet's stripping automated endothelial keratoplasty (DSAEK)], Ophthalmologe : Z. Dtsch. Ophthalmol. Ges., 106, 939, 10.1007/s00347-009-2024-z Cursiefen, 2011, Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes, J. Exp. Med., 208, 1083, 10.1084/jem.20092277 Cursiefen, 2004, Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis, Investig. Ophthalmol. Vis. Sci., 45, 1117, 10.1167/iovs.03-0940 Cursiefen, 2002, Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin, Investig. Ophthalmol. Vis. Sci., 43, 2127 Cursiefen, 2014, Aganirsen antisense oligonucleotide eye drops inhibit keratitis-induced corneal neovascularization and reduce need for transplantation: the I-can study, Ophthalmology, 121, 1683, 10.1016/j.ophtha.2014.03.038 Daniel, 2016, Comparison of long-term outcomes of femtosecond laser-assisted keratoplasty with conventional keratoplasty, Cornea, 35, 293, 10.1097/ICO.0000000000000739 Dastjerdi, 2010, Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival, Investig. Ophthalmol. Vis. Sci., 51, 2411, 10.1167/iovs.09-3745 Dekaris, 2015, Three-year corneal graft survival rate in high-risk cases treated with subconjunctival and topical bevacizumab, Graefe's Arch. Clin. Exp. Ophthalmol. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol., 253, 287, 10.1007/s00417-014-2851-8 DelMonte, 2011, Anatomy and physiology of the cornea, J. Cataract Refract. Surg., 37, 588, 10.1016/j.jcrs.2010.12.037 Deng, 2018, Descemet membrane endothelial keratoplasty: safety and outcomes: a report by the American academy of ophthalmology, Ophthalmology, 125, 295, 10.1016/j.ophtha.2017.08.015 Detry, 2013, Sunitinib inhibits inflammatory corneal lymphangiogenesis, Investig. Ophthalmol. Vis. Sci., 54, 3082, 10.1167/iovs.12-10856 Dhaliwal, 2008, Long-term use of topical tacrolimus (FK506) in high-risk penetrating keratoplasty, Cornea, 27, 488, 10.1097/ICO.0b013e3181606086 Dietrich, 2010, Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation, J. Immunol., 184, 535, 10.4049/jimmunol.0903180 Dietrich, 2007, Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockade, Am. J. Pathol., 171, 361, 10.2353/ajpath.2007.060896 Dilioglou, 2003, Function of CD80 and CD86 on monocyte- and stem cell-derived dendritic cells, Exp. Mol. Pathol., 75, 217, 10.1016/S0014-4800(03)00072-8 Dobrowolski, 2015, Cultivated oral mucosa epithelium in ocular surface reconstruction in aniridia patients, BioMed Res. Int., 2015, 281870, 10.1155/2015/281870 Dohlman, 2015, VEGF-trap aflibercept significantly improves long-term graft survival in high-risk corneal transplantation, Transplantation, 99, 678, 10.1097/TP.0000000000000512 Droutsas, 2016, Visual outcomes after descemet membrane endothelial keratoplasty versus descemet stripping automated endothelial keratoplasty-comparison of specific matched pairs, Cornea, 35, 765, 10.1097/ICO.0000000000000822 Du, 2017, Blockade of MMP-2 and MMP-9 inhibits corneal lymphangiogenesis, Graefe's Arch. Clin. Exp. Ophthalmol. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol., 255, 1573, 10.1007/s00417-017-3651-8 Dua, 2013, Human corneal anatomy redefined: a novel pre-Descemet's layer (Dua's layer), Ophthalmology, 120, 1778, 10.1016/j.ophtha.2013.01.018 Egeblad, 2002, New functions for the matrix metalloproteinases in cancer progression, Nat. Rev. Canc., 2, 161, 10.1038/nrc745 Eghrari, 2015, Overview of the cornea: structure, function, and development, Prog. Mol. Biol. Transl. Sci., 134, 7, 10.1016/bs.pmbts.2015.04.001 Elbaz, 2015, Corneal fine needle diathermy with adjuvant bevacizumab to treat corneal neovascularization in children, Cornea, 34, 773, 10.1097/ICO.0000000000000419 Ellis, 2008, VEGF-targeted therapy: mechanisms of anti-tumour activity, Nat. Rev. Canc., 8, 579, 10.1038/nrc2403 Emami-Naeini, 2014, Soluble vascular endothelial growth factor receptor-3 suppresses allosensitization and promotes corneal allograft survival, Graefe's Arch. Clin. Exp. Ophthalmol. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol., 252, 1755, 10.1007/s00417-014-2749-5 Enders, 2019, Telemetric intraocular pressure monitoring after Boston keratoprosthesis surgery, Ophthalmology, 126, 322, 10.1016/j.ophtha.2018.09.028 Eslani, 2012, Cultivated limbal and oral mucosal epithelial transplantation, Semin. Ophthalmol., 27, 80, 10.3109/08820538.2012.680641 Ezon, 2013, Immunologic graft rejection in descemet's stripping endothelial keratoplasty and penetrating keratoplasty for endothelial disease, Ophthalmology, 120, 1360, 10.1016/j.ophtha.2012.12.036 Faraj, 2014, Fine needle diathermy occlusion of corneal vessels, Br. J. Ophthalmol., 98, 1287, 10.1136/bjophthalmol-2014-304891 Fasciani, 2015, Subconjunctival and/or intrastromal bevacizumab injections as preconditioning therapy to promote corneal graft survival, Int. Ophthalmol., 35, 221, 10.1007/s10792-014-9938-4 Ferguson, 1997, A vision of cell death: insights into immune privilege, Immunol. Rev., 156, 167, 10.1111/j.1600-065X.1997.tb00967.x Ferrari, 2013, Topical Ranibizumab as a treatment of corneal neovascularization, Cornea, 32, 992, 10.1097/ICO.0b013e3182775f8d Figueiredo, 2015, Transplant rejection following endothelial keratoplasty and penetrating keratoplasty in the United Kingdom: incidence and survival, Am. J. Ophthalmol., 160, 416, 10.1016/j.ajo.2015.06.012 Figueiredo, 2015, Transplant rejection following endothelial keratoplasty and penetrating keratoplasty in the United Kingdom: incidence and survival, Am. J. Ophthalmol., 160, 416, 10.1016/j.ajo.2015.06.012 Figueiredo, 2018, Outcomes of penetrating keratoplasty following autologous cultivated limbal epithelial stem cell transplantation, Stem cells (Dayton, Ohio), 36, 925, 10.1002/stem.2803 Filipowicz, 2008, Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?, Nat. Rev. Genet., 9, 102, 10.1038/nrg2290 Fiorentzis, 2015, [Immunological graft rejection with Khodadoust line after "Descemet stripping automated endothelial keratoplasty" (DSAEK)], Ophthalmologe : Z. Dtsch. Ophthalmol. Ges., 112, 783, 10.1007/s00347-014-3226-6 Flockerzi, 2018, Trends in corneal transplantation from 2001 to 2016 in Germany: a report of the DOG-section cornea and its keratoplasty registry, Am. J. Ophthalmol., 188, 91, 10.1016/j.ajo.2018.01.018 Forrester, 2010, Dendritic cell physiology and function in the eye, Immunol. Rev., 234, 282, 10.1111/j.0105-2896.2009.00873.x Foster, 1993, Systemic (serum) soluble interleukin-2 receptor levels in corneal transplant recipients, Doc. Ophthalmol. Adv. Ophthalmol., 83, 83, 10.1007/BF01203574 Fritz, 2019, Avoiding hyperopic surprises after Descemet membrane endothelial keratoplasty in Fuchs dystrophy eyes by assessing corneal shape, Am. J. Ophthalmol., 197, 1, 10.1016/j.ajo.2018.08.052 Fukushima, 2011, Sema3E-PlexinD1 signaling selectively suppresses disoriented angiogenesis in ischemic retinopathy in mice, J. Clin. Investig., 121, 1974, 10.1172/JCI44900 Garmy-Susini, 2008, Roles of integrins in tumor angiogenesis and lymphangiogenesis, Lymphatic Res. Biol., 6, 155, 10.1089/lrb.2008.1011 Ghoraishi, 1995, Penetrating keratoplasty in atopic keratoconjunctivitis, Cornea, 14, 610, 10.1097/00003226-199511000-00015 Giannaccare, 2018, Immunologic stromal rejection after deep anterior lamellar keratoplasty with grafts of a larger size (9 mm) for various stromal diseases, Cornea, 37, 967, 10.1097/ICO.0000000000001584 Gibbons, 2019, Cost-effectiveness analysis of descemet membrane endothelial keratoplasty compared to descemet stripping endothelial keratoplasty in the United States of America, Ophthalmology, 126, 207, 10.1016/j.ophtha.2018.09.033 Gomer, 1988, Molecular, cellular, and tissue responses following photodynamic therapy, Lasers Surg. Med., 8, 450, 10.1002/lsm.1900080503 Gomes, 2015, Global consensus on keratoconus and ectatic diseases, Cornea, 34, 359, 10.1097/ICO.0000000000000408 Gonzalez, 2017, Immunologic rejection episodes after deep anterior lamellar keratoplasty: incidence and risk factors, Cornea, 36, 1076, 10.1097/ICO.0000000000001223 Gorovoy, 2014, DMEK complications, Cornea, 33, 101, 10.1097/ICO.0000000000000023 Goweida, 2015, Intraoperative review of different bubble types formed during pneumodissection (big-bubble) deep anterior lamellar keratoplasty, Cornea, 34, 621, 10.1097/ICO.0000000000000407 Grimaldo, 2015, MicroRNA-184 regulates corneal lymphangiogenesis, Investig. Ophthalmol. Vis. Sci., 56, 7209, 10.1167/iovs.15-17733 Guell, 2015, Comparison of sulfur hexafluoride 20% versus air tamponade in descemet membrane endothelial keratoplasty, Ophthalmology, 122, 1757, 10.1016/j.ophtha.2015.05.013 Guerra, 2011, Descemet's membrane endothelial keratoplasty: prospective study of 1-year visual outcomes, graft survival, and endothelial cell loss, Ophthalmology, 118, 2368, 10.1016/j.ophtha.2011.06.002 Gupta, 2011, Treatments for corneal neovascularization: a review, Cornea, 30, 927, 10.1097/ICO.0b013e318201405a Gupta, 2018, Early results of penetrating keratoplasty in patients with unilateral chemical injury after simple limbal epithelial transplantation, Cornea, 37, 1249, 10.1097/ICO.0000000000001681 Hahn, 1995, The association of lymphocytotoxic antibodies with corneal allograft rejection in high risk patients, Transplantation, 59, 21, 10.1097/00007890-199501150-00005 Hajrasouliha, 2012, Vascular endothelial growth factor-C promotes alloimmunity by amplifying antigen-presenting cell maturation and lymphangiogenesis, Investig. Ophthalmol. Vis. Sci., 53, 1244, 10.1167/iovs.11-8668 Ham, 2016, Midterm results of descemet membrane endothelial keratoplasty: 4 to 7 Years clinical outcome, Am. J. Ophthalmol., 171, 113, 10.1016/j.ajo.2016.08.038 Hamrah, 2003, Corneal immunity is mediated by heterogeneous population of antigen-presenting cells, J. Leukoc. Biol., 74, 172, 10.1189/jlb.1102544 Hamrah, 2003, The corneal stroma is endowed with a significant number of resident dendritic cells, Investig. Ophthalmol. Vis. Sci., 44, 581, 10.1167/iovs.02-0838 Hamrah, 2002, Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells, Investig. Ophthalmol. Vis. Sci., 43, 639 Hamzaoglu, 2015, The first 100 eyes of standardized descemet stripping automated endothelial keratoplasty versus standardized descemet membrane endothelial keratoplasty, Ophthalmology, 122, 2193, 10.1016/j.ophtha.2015.07.003 Han, 2015, Therapeutic effects of topical netrin-4 inhibits corneal neovascularization in alkali-burn rats, PLoS One, 10 Harding, 2001, Photodynamic therapy in the treatment of subfoveal choroidal neovascularisation, Eye, 15, 407, 10.1038/eye.2001.145 Hargrave, 2004, Fate of MHC-matched corneal allografts in Th1-deficient hosts, Investig. Ophthalmol. Vis. Sci., 45, 1188, 10.1167/iovs.03-0515 Hassell, 2010, The molecular basis of corneal transparency, Exp. Eye Res., 91, 326, 10.1016/j.exer.2010.06.021 Hegde, 2005, CD4(+) T-cell-mediated mechanisms of corneal allograft rejection: role of Fas-induced apoptosis, Transplantation, 79, 23, 10.1097/01.TP.0000147196.79546.69 Heindl, 2013, Split cornea transplantation: relationship between storage time of split donor tissue and outcome, Ophthalmology, 120, 899, 10.1016/j.ophtha.2012.11.012 Heindl, 2011, Split cornea transplantation for 2 recipients: a new strategy to reduce corneal tissue cost and shortage, Ophthalmology, 118, 294, 10.1016/j.ophtha.2010.05.025 Heindl, 2011, Split cornea transplantation for 2 recipients - review of the first 100 consecutive patients, Am. J. Ophthalmol., 152, 523, 10.1016/j.ajo.2011.03.021 Heinzelmann, 2017, Descemet membrane endothelial keratoplasty for graft failure following penetrating keratoplasty, Graefe's Arch. Clin. Exp. Ophthalmol. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol., 255, 979, 10.1007/s00417-017-3600-6 Heinzelmann, 2015, Cystoid macular oedema following Descemet membrane endothelial keratoplasty, Br. J. Ophthalmol., 99, 98, 10.1136/bjophthalmol-2014-305124 Heishi, 2010, Endogenous angiogenesis inhibitor vasohibin1 exhibits broad-spectrum antilymphangiogenic activity and suppresses lymph node metastasis, Am. J. Pathol., 176, 1950, 10.2353/ajpath.2010.090829 Heldin, 1999, Mechanism of action and in vivo role of platelet-derived growth factor, Physiol. Rev., 79, 1283, 10.1152/physrev.1999.79.4.1283 Henderson, 1992, How does photodynamic therapy work?, Photochem. Photobiol., 55, 145, 10.1111/j.1751-1097.1992.tb04222.x Hill, 1989, The use of cyclosporine in high-risk keratoplasty, Am. J. Ophthalmol., 107, 506, 10.1016/0002-9394(89)90494-7 Hill, 1994, Systemic cyclosporine in high-risk keratoplasty. Short- versus long-term therapy, Ophthalmology, 101, 128, 10.1016/S0161-6420(13)31253-6 Hill, 1995, Systemic cyclosporine in high-risk keratoplasty: long-term results, Eye, 9, 422, 10.1038/eye.1995.99 Hjortdal, 2009, Descemet's stripping automated endothelial keratoplasty and penetrating keratoplasty for Fuchs' endothelial dystrophy, Acta Ophthalmol., 87, 310, 10.1111/j.1755-3768.2008.01492.x Hock, 2009, Release and clinical significance of soluble CD83 in chronic lymphocytic leukemia, Leuk. Res., 33, 1089, 10.1016/j.leukres.2009.01.001 Hock, 2004, The soluble form of CD83 is present at elevated levels in a number of hematological malignancies, Leuk. Res., 28, 237, 10.1016/S0145-2126(03)00255-8 Hock, 2001, A soluble form of CD83 is released from activated dendritic cells and B lymphocytes, and is detectable in normal human sera, Int. Immunol., 13, 959, 10.1093/intimm/13.7.959 Hoerster, 2016, Intensified topical steroids as prophylaxis for macular edema after posterior lamellar keratoplasty combined with cataract surgery, Am. J. Ophthalmol., 163, 174, 10.1016/j.ajo.2015.12.008 Hoffmann, 1986, Topical cyclosporin A in the treatment of corneal graft reaction, Cornea, 5, 129, 10.1097/00003226-198605030-00001 Holzer, 2003, Photodynamic therapy with verteporfin in a rabbit model of corneal neovascularization, Investig. Ophthalmol. Vis. Sci., 44, 2954, 10.1167/iovs.02-0572 Hong, 2003, Prox1, master regulator of the lymphatic vasculature phenotype, Cell Tissue Res., 314, 85, 10.1007/s00441-003-0747-8 Hong, 2002, Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate, Dev. Dynam., 225, 351, 10.1002/dvdy.10163 Hori, 2001, Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice, Investig. Ophthalmol. Vis. Sci., 42, 720 Horie, 2009, Human iris pigment epithelium suppresses activation of bystander T cells via TGFbeta-TGFbeta receptor interaction, Exp. Eye Res., 88, 1033, 10.1016/j.exer.2009.01.011 Horstmann, 2017, Label-free in vivo imaging of corneal lymphatic vessels using microscopic optical coherence tomography, Investig. Ophthalmol. Vis. Sci., 58, 5880, 10.1167/iovs.17-22286 Hos, 2008, Inflammatory corneal (lymph)angiogenesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation, Investig. Ophthalmol. Vis. Sci., 49, 1836, 10.1167/iovs.07-1314 Hos, 2016, IL-10 indirectly regulates corneal lymphangiogenesis and resolution of inflammation via macrophages, Am. J. Pathol., 186, 159, 10.1016/j.ajpath.2015.09.012 Hos, 2017, Transient ingrowth of lymphatic vessels into the physiologically avascular cornea regulates corneal edema and transparency, Sci. Rep., 10.1038/s41598-017-07806-4 Hos, 2016, Blockade of CCR7 leads to decreased dendritic cell migration to draining lymph nodes and promotes graft survival in low-risk corneal transplantation, Exp. Eye Res., 146, 1, 10.1016/j.exer.2015.12.004 Hos, 2014, Evidence of donor corneal endothelial cell migration from immune reactions occurring after descemet membrane endothelial keratoplasty, Cornea, 33, 331, 10.1097/ICO.0000000000000054 Hos, 2019, Risk of corneal graft rejection after high-risk keratoplasty following fine-needle vessel coagulation of corneal neovascularization combined with bevacizumab: a pilot study, Transplant. Dir., 5, e452, 10.1097/TXD.0000000000000894 Hos, 2011, Blockade of insulin receptor substrate-1 inhibits corneal lymphangiogenesis, Investig. Ophthalmol. Vis. Sci., 52, 5778, 10.1167/iovs.10-6816 Hos, 2011, Suppression of inflammatory corneal lymphangiogenesis by application of topical corticosteroids, Arch. Ophthalmol., 129, 445, 10.1001/archophthalmol.2011.42 Hos, 2019, Does anterior chamber-associated immune deviation (ACAID) play a role in posterior lamellar keratoplasty? Case report of a splenectomized patient, BMC Ophthalmol., 19, 100, 10.1186/s12886-019-1114-1 Hos, 2015, Antilymphangiogenic therapy to promote transplant survival and to reduce cancer metastasis: what can we learn from the eye?, Semin. Cell Dev. Biol., 38, 117, 10.1016/j.semcdb.2014.11.003 Hos, 2017, Incidence and clinical course of immune reactions after descemet membrane endothelial keratoplasty: retrospective analysis of 1000 consecutive eyes, Ophthalmology, 124, 512, 10.1016/j.ophtha.2016.12.017 Hou, 2017, Photodynamic therapy leads to time-dependent regression of pathologic corneal (lymph) angiogenesis and promotes high-risk corneal allograft survival, Investig. Ophthalmol. Vis. Sci., 58, 5862, 10.1167/iovs.17-22904 Hou, 2018, UV light crosslinking regresses mature corneal blood and lymphatic vessels and promotes subsequent high-risk corneal transplant survival, Am. J. Transplant., 18, 2873, 10.1111/ajt.14874 Huq, 2004, Relevance of the direct pathway of sensitization in corneal transplantation is dictated by the graft bed microenvironment, J. Immunol., 173, 4464, 10.4049/jimmunol.173.7.4464 Hussain, 2017, Fine-needle diathermy with simultaneous subconjunctival bevacizumab, Semin. Ophthalmol., 32, 550, 10.3109/08820538.2015.1123738 Inoue, 2001, Risk factors for corneal graft failure and rejection in penetrating keratoplasty, Acta Ophthalmol. Scand., 79, 251, 10.1034/j.1600-0420.2001.790308.x Iovieno, 2017, Descemetorhexis without graft placement for the treatment of Fuchs endothelial dystrophy: preliminary results and review of the literature, Cornea, 36, 637, 10.1097/ICO.0000000000001202 Ishino, 2004, Amniotic membrane as a carrier for cultivated human corneal endothelial cell transplantation, Investig. Ophthalmol. Vis. Sci., 45, 800, 10.1167/iovs.03-0016 Jeong, 2019, Retinal pigment epithelium-derived transforming growth factor-beta2 inhibits the angiogenic response of endothelial cells by decreasing vascular endothelial growth factor receptor-2 expression, J. Cell. Physiol., 234, 3837, 10.1002/jcp.27156 Jiang, 2018, Lymphatic dysfunction, leukotrienes, and lymphedema, Annu. Rev. Physiol., 80, 49, 10.1146/annurev-physiol-022516-034008 Jitariu, 2015, Platelet-derived growth factors induced lymphangiogenesis: evidence, unanswered questions and upcoming challenges, Arch. Med. Sci., 11, 57, 10.5114/aoms.2015.49217 Johnson, 2017, Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1, Nat. Immunol., 18, 762, 10.1038/ni.3750 Johnson, 2006, An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium, J. Exp. Med., 203, 2763, 10.1084/jem.20051759 Jonas, 2002, Immunologic graft reactions after allogenic penetrating keratoplasty, Am. J. Ophthalmol., 133, 437, 10.1016/S0002-9394(01)01426-X Jones, 2012, Mirtron microRNA-1236 inhibits VEGFR-3 signaling during inflammatory lymphangiogenesis, Arterioscler. Thromb. Vasc. Biol., 32, 633, 10.1161/ATVBAHA.111.243576 Jordan, 2009, Graft rejection episodes after Descemet stripping with endothelial keratoplasty: part one: clinical signs and symptoms, Br. J. Ophthalmol., 93, 387, 10.1136/bjo.2008.140020 Joseph, 2007, Tacrolimus immunosuppression in high-risk corneal grafts, Br. J. Ophthalmol., 91, 51, 10.1136/bjo.2006.097428 Joyce, 2002, Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2, Investig. Ophthalmol. Vis. Sci., 43, 2152 Kajiya, 2005, Hepatocyte growth factor promotes lymphatic vessel formation and function, EMBO J., 24, 2885, 10.1038/sj.emboj.7600763 Kanellopoulos, 2014, Long-term safety and efficacy of high-fluence collagen crosslinking of the vehicle cornea in Boston keratoprosthesis type 1, Cornea, 33, 914, 10.1097/ICO.0000000000000176 Kang, 2016, Integrin alpha 9 blockade suppresses lymphatic valve formation and promotes transplant survival, Investig. Ophthalmol. Vis. Sci., 57, 5935, 10.1167/iovs.16-20130 Kataru, 2009, Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution, Blood, 113, 5650, 10.1182/blood-2008-09-176776 Kazenwadel, 2010, Prox1 expression is negatively regulated by miR-181 in endothelial cells, Blood, 116, 2395, 10.1182/blood-2009-12-256297 Kerjaschki, 2006, Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants, Nat. Med., 12, 230, 10.1038/nm1340 Khan, 2015, Descemet's stripping automated endothelial keratoplasty tissue insertion devices, J. Ophthalmic Vis. Res., 10, 461, 10.4103/2008-322X.176899 Khodadoust, 1969, Transplantation and rejection of individual cell layers of the cornea, Investig. Ophthalmol., 8, 180 Kim, 2012, Outcomes of repeat endothelial keratoplasty in patients with failed Descemet stripping endothelial keratoplasty, Cornea, 31, 1154, 10.1097/ICO.0b013e31823d1f03 Kinoshita, 2018, Injection of cultured cells with a ROCK inhibitor for bullous keratopathy, N. Engl. J. Med., 378, 995, 10.1056/NEJMoa1712770 Koenig, 2015, Planned descemetorhexis without endothelial keratoplasty in eyes with Fuchs corneal endothelial dystrophy, Cornea, 34, 1149, 10.1097/ICO.0000000000000531 Koenig, 2009, Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization, Graefe's Arch. Clin. Exp. Ophthalmol. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol., 247, 1375, 10.1007/s00417-009-1099-1 Koenig, 2012, Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: fine-needle vessel coagulation combined with anti-VEGFs, Cornea, 31, 887, 10.1097/ICO.0b013e31823f8f7a Koizumi, 2007, Cultivated corneal endothelial cell sheet transplantation in a primate model, Investig. Ophthalmol. Vis. Sci., 48, 4519, 10.1167/iovs.07-0567 Komai, 1991, The three-dimensional organization of collagen fibrils in the human cornea and sclera, Investig. Ophthalmol. Vis. Sci., 32, 2244 Kretschmer, 2009, Engagement of CD83 on B cells modulates B cell function in vivo, J. Immunol., 182, 2827, 10.4049/jimmunol.0803153 Kruse, 2014, Optimizing outcomes with Descemet's membrane endothelial keratoplasty, Curr. Opin. Ophthalmol., 25, 325, 10.1097/ICU.0000000000000072 Krzyzak, 2016, CD83 modulates B cell activation and germinal center responses, J. Immunol., 196, 3581, 10.4049/jimmunol.1502163 Ksander, 1991, Infiltration and accumulation of precursor cytotoxic T-cells increase with time in progressively growing ocular tumors, Cancer Res., 51, 3153 Ksander, 1990, Failure of infiltrating precursor cytotoxic T cells to acquire direct cytotoxic function in immunologically privileged sites, J. Immunol., 145, 2057, 10.4049/jimmunol.145.7.2057 Kubaloglu, 2011, Long-term results of deep anterior lamellar keratoplasty for the treatment of keratoconus, Am. J. Ophthalmol., 151, 760, 10.1016/j.ajo.2010.11.020 Kuchle, 2002, Risk factors for corneal allograft rejection: intermediate results of a prospective normal-risk keratoplasty study, Graefe's Arch. Clin. Exp. Ophthalmol. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol., 240, 580, 10.1007/s00417-002-0496-5 Kuffova, 2016, High-risk corneal graft rejection in the setting of previous corneal herpes simplex virus (HSV)-1 infection, Investig. Ophthalmol. Vis. Sci., 57, 1578, 10.1167/iovs.15-17894 Kuffova, 2001, Kinetics of leukocyte and myeloid cell traffic in the murine corneal allograft response, Transplantation, 72, 1292, 10.1097/00007890-200110150-00019 Lam, 2014, Hemi-Descemet membrane endothelial keratoplasty transplantation: a potential method for increasing the pool of endothelial graft tissue, JAMA Ophthalmol., 132, 1469, 10.1001/jamaophthalmol.2014.3328 Lan, 2010, Prevention of chronic renal allograft rejection by soluble CD83, Transplantation, 90, 1278, 10.1097/TP.0b013e318200005c Le, 2018, Novel method to detect corneal lymphatic vessels in vivo by intrastromal injection of fluorescein, Cornea, 37, 267, 10.1097/ICO.0000000000001444 Le, 2018, Fine needle-diathermy regresses pathological corneal (Lymph)Angiogenesis and promotes high-risk corneal transplant survival, Sci. Rep., 8, 5707, 10.1038/s41598-018-24037-3 Lechmann, 2001, The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells, J. Exp. Med., 194, 1813, 10.1084/jem.194.12.1813 Lee, 2012, NF-kappaB is the transcription factor for FGF-2 that causes endothelial mesenchymal transformation in cornea, Investig. Ophthalmol. Vis. Sci., 53, 1530, 10.1167/iovs.11-9102 Lee, 2015, Boston keratoprosthesis: outcomes and complications: a report by the American academy of ophthalmology, Ophthalmology, 122, 1504, 10.1016/j.ophtha.2015.03.025 Li, 2012, Three-year visual acuity outcomes after Descemet's stripping automated endothelial keratoplasty, Ophthalmology, 119, 1126, 10.1016/j.ophtha.2011.12.037 Li, 2012, Graft rejection after Descemet's stripping automated endothelial keratoplasty: graft survival and endothelial cell loss, Ophthalmology, 119, 90, 10.1016/j.ophtha.2011.07.007 Li, 2012, The expression and function of netrin-4 in murine ocular tissues, Exp. Eye Res., 96, 24, 10.1016/j.exer.2012.01.007 Li, 2012, Activated macrophages induce neovascularization through upregulation of MMP-9 and VEGF in rat corneas, Cornea, 31, 1028, 10.1097/ICO.0b013e31823f8b40 Lipp, 2014, Blockade of the VEGF isoforms in inflammatory corneal hemangiogenesis and lymphangiogenesis, Graefe's Arch. Clin. Exp. Ophthalmol. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol., 252, 943, 10.1007/s00417-014-2626-2 Liu, 2002, Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts, J. Exp. Med., 195, 259, 10.1084/jem.20010838 Luznik, 2019, Descemet membrane endothelial keratoplasty failure associated with innate immune activation, Ophthalmology Maguire, 1994, Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group, Ophthalmology, 101, 1536, 10.1016/S0161-6420(94)31138-9 Maier, 2017, Netrin-4 mediates corneal hemangiogenesis but not lymphangiogenesis in the mouse-model of suture-induced neovascularization, Investig. Ophthalmol. Vis. Sci., 58, 1387, 10.1167/iovs.16-19249 Makinen, 2001, Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3, Nat. Med., 7, 199, 10.1038/84651 Mannis, 1981, Keratoplasty: a historical perspective, Surv. Ophthalmol., 25, 333, 10.1016/0039-6257(81)90159-4 Marsland, 2005, CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells, Immunity, 22, 493, 10.1016/j.immuni.2005.02.010 Maruyama, 2007, Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing, Am. J. Pathol., 170, 1178, 10.2353/ajpath.2007.060018 Maruyama, 2005, Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages, J. Clin. Investig., 115, 2363, 10.1172/JCI23874 Maruyama, 2012, The maintenance of lymphatic vessels in the cornea is dependent on the presence of macrophages, Investig. Ophthalmol. Vis. Sci., 53, 3145, 10.1167/iovs.11-8010 Maruyama, 2014, The effect of podoplanin inhibition on lymphangiogenesis under pathological conditions, Investig. Ophthalmol. Vis. Sci., 55, 4813, 10.1167/iovs.13-13711 Matthaei, 2018, Technik der „Descemet membrane endothelial keratoplasty“ (DMEK): videobeitrag. Der Ophthalmologe, Z. Dtsch. Ophthalmol. Ges., 115, 778 McCawley, 2000, Matrix metalloproteinases: multifunctional contributors to tumor progression, Mol. Med. Today, 6, 149, 10.1016/S1357-4310(00)01686-5 McLaren, 2014, Objective assessment of the corneal endothelium in Fuchs' endothelial dystrophy, Investig. Ophthalmol. Vis. Sci., 55, 1184, 10.1167/iovs.13-13041 Medawar, 1948, Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye, Br. J. Exp. Pathol., 29, 58 Melles, 2006, Descemet membrane endothelial keratoplasty (DMEK), Cornea, 25, 987, 10.1097/01.ico.0000248385.16896.34 Melles, 2004, A technique to excise the descemet membrane from a recipient cornea (descemetorhexis), Cornea, 23, 286, 10.1097/00003226-200404000-00011 Mencucci, 2010, Effects of riboflavin/UVA corneal cross-linking on keratocytes and collagen fibres in human cornea, Clin. Exp. Ophthalmol., 38, 49, 10.1111/j.1442-9071.2010.02207.x Mimura, 2004, Cultured human corneal endothelial cell transplantation with a collagen sheet in a rabbit model, Investig. Ophthalmol. Vis. Sci., 45, 2992, 10.1167/iovs.03-1174 Mitry, 2014, Descemet stripping automated endothelial keratoplasty after failed penetrating keratoplasty: survival, rejection risk, and visual outcome, JAMA Ophthalmol., 132, 742, 10.1001/jamaophthalmol.2014.352 Miyamoto, 2010, Endothelial mesenchymal transition: a therapeutic target in retrocorneal membrane, Cornea, 29, S52, 10.1097/ICO.0b013e3181efe36a Moffatt, 2005, Centennial review of corneal transplantation, Clin. Exp. Ophthalmol., 33, 642, 10.1111/j.1442-9071.2005.01134.x Monnereau, 2014, Endothelial cell changes as an indicator for upcoming allograft rejection following descemet membrane endothelial keratoplasty, Am. J. Ophthalmol., 158, 485, 10.1016/j.ajo.2014.05.030 Mukherjee, 2009, A comprehensive review of immunosuppression used for liver transplantation, J. Transplant., 2009, 701464, 10.1155/2009/701464 Nguyen, 2009, Atopic dermatitis as a risk factor for graft rejection following normal-risk keratoplasty, Graefe's Arch. Clin. Exp. Ophthalmol. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol., 247, 573, 10.1007/s00417-008-0959-4 Nguyen, 2007, Long-term topical steroid treatment improves graft survival following normal-risk penetrating keratoplasty, Am. J. Ophthalmol., 144, 318, 10.1016/j.ajo.2007.03.028 Niederkorn, 1981, Deviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice, Investig. Ophthalmol. Vis. Sci., 20, 355 Niederkorn, 1990, Immune privilege and immune regulation in the eye, Adv. Immunol., 48, 191, 10.1016/S0065-2776(08)60755-5 Niederkorn, 2007, Immune mechanisms of corneal allograft rejection, Curr. Eye Res., 32, 1005, 10.1080/02713680701767884 Niederkorn, 2009, Allergic airway hyperreactivity increases the risk for corneal allograft rejection, Am. J. Transplant. : Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg., 9, 1017, 10.1111/j.1600-6143.2009.02603.x Niederkorn, 2010, Allergic conjunctivitis exacerbates corneal allograft rejection by activating Th1 and th2 alloimmune responses, J. Immunol., 184, 6076, 10.4049/jimmunol.0902300 Niederkorn, 1996, Anterior chamber-associated immune deviation promotes corneal allograft survival, Investig. Ophthalmol. Vis. Sci., 37, 2700 Noble, 2007, Deep Anterior Lamellar Keratoplasty (DALK): visual outcome and complications for a heterogeneous group of corneal pathologies, Cornea, 26, 59, 10.1097/01.ico.0000240080.99832.f3 Notara, 2010, In sickness and in health: corneal epithelial stem cell biology, pathology and therapy, Exp. Eye Res., 90, 188, 10.1016/j.exer.2009.09.023 Notara, 2008, Biological principals and clinical potentials of limbal epithelial stem cells, Cell Tissue Res., 331, 135, 10.1007/s00441-007-0458-7 Notara, 2018, The role of limbal epithelial stem cells in regulating corneal (Lymph)angiogenic privilege and the micromilieu of the limbal niche following UV exposure, Stem Cell. Int., 2018, 8620172 Notara, 2015, Short-term uvb-irradiation leads to putative limbal stem cell damage and niche cell-mediated upregulation of macrophage recruiting cytokines, Stem Cell Res., 15, 643, 10.1016/j.scr.2015.10.008 Notara, 2016, Short-term ultraviolet a irradiation leads to dysfunction of the limbal niche cells and an antilymphangiogenic and anti-inflammatory micromilieu, Investig. Ophthalmol. Vis. Sci., 57, 928, 10.1167/iovs.15-18343 Novak, 2003, The good, the bad and the ugly--APCs of the eye, Trends Immunol., 24, 570, 10.1016/j.it.2003.09.009 Nubile, 2013, In vivo confocal microscopy in diagnosis of limbal stem cell deficiency, Am. J. Ophthalmol., 155, 220, 10.1016/j.ajo.2012.08.017 Oh, 2018, MiR-199a/b-5p inhibits lymphangiogenesis by targeting discoidin domain receptor 1 in corneal injury, Mol. Cells, 41, 93 Oh, 1997, VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane, Dev. Biol., 188, 96, 10.1006/dbio.1997.8639 Ohl, 2004, CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions, Immunity, 21, 279, 10.1016/j.immuni.2004.06.014 Oka, 2008, Inhibition of endogenous TGF-beta signaling enhances lymphangiogenesis, Blood, 111, 4571, 10.1182/blood-2007-10-120337 Okumura, 2015, Laminin-511 and -521 enable efficient in vitro expansion of human corneal endothelial cells, Investig. Ophthalmol. Vis. Sci., 56, 2933, 10.1167/iovs.14-15163 Okumura, 2012, ROCK inhibitor converts corneal endothelial cells into a phenotype capable of regenerating in vivo endothelial tissue, Am. J. Pathol., 181, 268, 10.1016/j.ajpath.2012.03.033 Okumura, 2016, Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction, Sci. Rep., 6, 26113, 10.1038/srep26113 Okumura, 2009, Enhancement on primate corneal endothelial cell survival in vitro by a ROCK inhibitor, Investig. Ophthalmol. Vis. Sci., 50, 3680, 10.1167/iovs.08-2634 Olson, 2012, Stromal rejection following deep anterior lamellar keratoplasty: implications for postoperative care, Cornea, 31, 969, 10.1097/ICO.0b013e31823f8a99 Osawa, 2004, CD95 ligand expression on corneal epithelium and endothelium influences the fates of orthotopic and heterotopic corneal allografts in mice, Investig. Ophthalmol. Vis. Sci., 45, 1908, 10.1167/iovs.03-0512 Osei-Bempong, 2013, The limbal epithelium of the eye--a review of limbal stem cell biology, disease and treatment, Bioessays : News Rev. Mol. Cell Dev. Biol., 35, 211, 10.1002/bies.201200086 Otrock, 2007, Vascular endothelial growth factor family of ligands and receptors: review, Blood Cells Mol. Dis., 38, 258, 10.1016/j.bcmd.2006.12.003 Panda, 2007, Corneal graft rejection, Surv. Ophthalmol., 52, 375, 10.1016/j.survophthal.2007.04.008 Pardoll, 2002, Spinning molecular immunology into successful immunotherapy, Nat. Rev. Immunol., 2, 227, 10.1038/nri774 Paunicka, 2015, Severing corneal nerves in one eye induces sympathetic loss of immune privilege and promotes rejection of future corneal allografts placed in either eye, Am. J. Transplant. : Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg., 15, 1490, 10.1111/ajt.13240 Pellegrini, 2018, Navigating market authorization: the path holoclar took to become the first stem cell product approved in the European Union, Stem Cell. Transl. Med., 7, 146, 10.1002/sctm.17-0003 Pellegrini, 2014, Eyes on the prize: limbal stem cells and corneal restoration, Cell stem cell, 15, 121, 10.1016/j.stem.2014.07.011 Pepper, 1994, In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells, Exp. Cell Res., 210, 298, 10.1006/excr.1994.1042 Peppicelli, 2014, Inflammatory cytokines induce vascular endothelial growth factor-C expression in melanoma-associated macrophages and stimulate melanoma lymph node metastasis, Oncol Lett, 8, 1133, 10.3892/ol.2014.2297 Peraza-Nieves, 2017, Two-year clinical outcome of 500 consecutive cases undergoing descemet membrane endothelial keratoplasty, Cornea, 36, 655, 10.1097/ICO.0000000000001176 Pillai, 2000, Fine needle diathermy occlusion of corneal vessels, Investig. Ophthalmol. Vis. Sci., 41, 2148 Podgrabinska, 2009, Inflamed lymphatic endothelium suppresses dendritic cell maturation and function via Mac-1/ICAM-1-dependent mechanism, J. Immunol., 183, 1767, 10.4049/jimmunol.0802167 Poon, 2001, Systemic cyclosporin A in high risk penetrating keratoplasties: a case-control study, Br. J. Ophthalmol., 85, 1464, 10.1136/bjo.85.12.1464 Prechtel, 2007, CD83 knockdown in monocyte-derived dendritic cells by small interfering RNA leads to a diminished T cell stimulation, J. Immunol., 178, 5454, 10.4049/jimmunol.178.9.5454 Preclik, 2010, [Long-term outcome after penetrating keratoplasty for keratoconus--impact of preoperative corneal curvature and best corrected visual acuity on the functional results], Klin. Monatsblatter Augenheilkd., 227, 199, 10.1055/s-0028-1109739 Price, 2018, Five-year graft survival of descemet membrane endothelial keratoplasty (EK) versus descemet stripping EK and the effect of donor sex matching, Ophthalmology, 125, 1508, 10.1016/j.ophtha.2018.03.050 Price, 2006, Descemet's stripping with endothelial keratoplasty in 200 eyes: early challenges and techniques to enhance donor adherence, J. Cataract Refract. Surg., 32, 411, 10.1016/j.jcrs.2005.12.078 Price, 2008, Randomized, prospective comparison of precut vs surgeon-dissected grafts for descemet stripping automated endothelial keratoplasty, Am. J. Ophthalmol., 146, 36, 10.1016/j.ajo.2008.02.024 Price, 2011, Descemet's stripping endothelial keratoplasty five-year graft survival and endothelial cell loss, Ophthalmology, 118, 725, 10.1016/j.ophtha.2010.08.012 Price, 2015, Loteprednol etabonate 0.5% gel vs. Prednisolone acetate 1% solution after descemet membrane endothelial keratoplasty: prospective randomized trial, Cornea, 34, 853, 10.1097/ICO.0000000000000475 Price, 2009, Descemet's membrane endothelial keratoplasty: prospective multicenter study of visual and refractive outcomes and endothelial survival, Ophthalmology, 116, 2361, 10.1016/j.ophtha.2009.07.010 Price, 2017, EK (DLEK, DSEK, DMEK): new frontier in cornea surgery, Annu. Rev. Vis. Sci., 3, 69, 10.1146/annurev-vision-102016-061400 Price, 2009, Graft rejection episodes after Descemet stripping with endothelial keratoplasty: part two: the statistical analysis of probability and risk factors, Br. J. Ophthalmol., 93, 391, 10.1136/bjo.2008.140038 Price, 2014, Randomized comparison of topical prednisolone acetate 1% versus fluorometholone 0.1% in the first year after descemet membrane endothelial keratoplasty, Cornea, 33, 880, 10.1097/ICO.0000000000000206 Price, 2016, Descemet's membrane endothelial keratoplasty: risk of immunologic rejection episodes after discontinuing topical corticosteroids, Ophthalmology, 123, 1232, 10.1016/j.ophtha.2016.02.001 Quilendrino, 2017, Prevention and management of descemet membrane endothelial keratoplasty complications, Cornea, 36, 1089, 10.1097/ICO.0000000000001262 Raiskup, 2013, Corneal crosslinking with riboflavin and ultraviolet A. I. Principles, Ocul. Surf., 11, 65, 10.1016/j.jtos.2013.01.002 Rama, 2010, Limbal stem-cell therapy and long-term corneal regeneration, N. Engl. J. Med., 363, 147, 10.1056/NEJMoa0905955 Ramamoorthy, 2016, Corticosteroids: mechanisms of action in health and disease, Rheum. Dis. Clin. N. Am., 42, 15, 10.1016/j.rdc.2015.08.002 Randolph, 1999, Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation, J. Clin. Investig., 104, 1021, 10.1172/JCI7631 Ray, 2002, Pseudophakic cystoid macular edema, Semin. Ophthalmol., 17, 167, 10.1076/soph.17.3.167.14794 Reed, 1988, The effect of photodynamic therapy on the microcirculation, J. Surg. Res., 45, 452, 10.1016/0022-4804(88)90195-3 Regenfuss, 2012, Corneal angiogenesis and lymphangiogenesis, Curr. Opin. Allergy Clin. Immunol., 12, 548, 10.1097/ACI.0b013e328357b4a2 Regenfuss, 2015, The naive murine cornea as a model system to identify novel endogenous regulators of lymphangiogenesis: TRAIL and rtPA, Lymphatic Res. Biol., 13, 76, 10.1089/lrb.2015.0004 Regenfuss, 2010, Genetic heterogeneity of lymphangiogenesis in different mouse strains, Am. J. Pathol., 177, 501, 10.2353/ajpath.2010.090794 Reimer, 2012, [Long-term outcome after penetrating keratoplasty for bullous keratopathy - influence of preoperative visual acuity on final outcome], Klin. Monatsblatter Augenheilkd., 229, 149, 10.1055/s-0031-1281760 Reinhard, 2005, Systemic mycophenolate mofetil avoids immune reactions in penetrating high-risk keratoplasty: preliminary results of an ongoing prospectively randomized multicentre study, Transpl. Int. : Off. J. Eur. Soc. Organ Transplant., 18, 703, 10.1111/j.1432-2277.2005.00126.x Reinhard, 1999, Penetrating keratoplasty in patients with atopic dermatitis with and without systemic cyclosporin A, Cornea, 18, 645, 10.1097/00003226-199911000-00003 Reinhart, 2011, Deep anterior lamellar keratoplasty as an alternative to penetrating keratoplasty a report by the american academy of ophthalmology, Ophthalmology, 118, 209, 10.1016/j.ophtha.2010.11.002 Reinke, 1999, Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey, Ophthalmology, 106, 1915, 10.1016/S0161-6420(99)90401-3 Reis, 1999, Mycophenolate mofetil versus cyclosporin A in high risk keratoplasty patients: a prospectively randomised clinical trial, Br. J. Ophthalmol., 83, 1268, 10.1136/bjo.83.11.1268 Reuer, 2018, Semaphorin 3F modulates corneal lymphangiogenesis and promotes corneal graft survival, Investig. Ophthalmol. Vis. Sci., 59, 5277, 10.1167/iovs.18-24287 Reuten, 2016, Structural decoding of netrin-4 reveals a regulatory function towards mature basement membranes, Nat. Commun., 7, 13515, 10.1038/ncomms13515 Ribatti, 2009, Endogenous inhibitors of angiogenesis: a historical review, Leuk. Res., 33, 638, 10.1016/j.leukres.2008.11.019 Riss, 2012, Pentacam-based big bubble deep anterior lamellar keratoplasty in patients with keratoconus, Cornea, 31, 627, 10.1097/ICO.0b013e31823f8c85 Riss, 2013, Microbubble incision as a new rescue technique for big-bubble deep anterior lamellar keratoplasty with failed bubble formation, Cornea, 32, 125, 10.1097/ICO.0b013e31824a226f Robert, 2017, Infliximab after Boston keratoprosthesis in stevens-johnson syndrome: an update, Ocul. Immunol. Inflamm., 25, 413, 10.3109/09273948.2016.1145237 Roberts, 2016, Late stromal rejection in deep anterior lamellar keratoplasty: a case series, Cornea, 35, 1179, 10.1097/ICO.0000000000000890 Rodriguez-Calvo-de-Mora, 2015, Clinical outcome of 500 consecutive cases undergoing Descemet's membrane endothelial keratoplasty, Ophthalmology, 122, 464, 10.1016/j.ophtha.2014.09.004 Romano, 2015, Long-term clinical outcomes of deep anterior lamellar keratoplasty in patients with keratoconus, Am. J. Ophthalmol., 159, 505, 10.1016/j.ajo.2014.11.033 Ross, 1991, Evidence that the fate of class II-disparate corneal grafts is determined by the timing of class II expression, Transplantation, 51, 532, 10.1097/00007890-199102000-00049 Ross, 1991, Class I disparate corneal grafts enjoy afferent but not efferent blockade of the immune response, Curr. Eye Res., 10, 889, 10.3109/02713689109013885 Saban, 2010, Thrombospondin-1 derived from APCs regulates their capacity for allosensitization, J. Immunol., 185, 4691, 10.4049/jimmunol.1001133 Saban, 2009, 'Chimeric' grafts assembled from multiple allodisparate donors enjoy enhanced transplant survival, Am. J. Transplant. : Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg., 9, 473, 10.1111/j.1600-6143.2008.02535.x Saelens, 2011, A posterior khodadoust line in a graft rejection episode after descemet stripping automated endothelial keratoplasty, Cornea, 30, 245, 10.1097/ICO.0b013e3181ec9080 Salabarria, 2019, Local VEGF-A blockade modulates the microenvironment of the corneal graft bed, Am. J. Transplant., 10.1111/ajt.15331 Salouti, 2019, Comparison between manual trephination versus femtosecond laser-assisted deep anterior lamellar keratoplasty for keratoconus, Br. J. Ophthalmol., 10.1136/bjophthalmol-2018-313365 Sanchez-Fueyo, 2011, Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs, Gastroenterology, 140, 51, 10.1053/j.gastro.2010.10.059 Sangwan, 2005, Early results of penetrating keratoplasty following limbal stem cell transplantation, Indian J. Ophthalmol., 53, 31, 10.4103/0301-4738.15282 Sano, 2000, Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition, Investig. Ophthalmol. Vis. Sci., 41, 1422 Sarnicola, 2016, Cannula DALK versus needle DALK for keratoconus, Cornea, 35, 1508, 10.1097/ICO.0000000000001032 Savetsky, 2015, Th2 cytokines inhibit lymphangiogenesis, PLoS One, 10, 10.1371/journal.pone.0126908 Schaub, 2019, Midterm follow-up of immune reactions after Descemet membrane endothelial keratoplasty (DMEK), Graefe’s Arch. Clin. Exp. Ophthalmol. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol., 10.1007/s00417-019-04357-4 Schaub, 2015, Retrospective appraisal of split-cornea transplantation: an audit of 1141 donor corneas, JAMA Ophthalmol., 133, 1086, 10.1001/jamaophthalmol.2015.1684 Schaub, 2017, Impact of donor graft quality on deep anterior lamellar Keratoplasty (DALK), BMC Ophthalmol., 17, 204, 10.1186/s12886-017-0600-6 Schaub, 2017, Single-pass ultrathin DSAEK (UT-DSAEK) with the SLc expert microkeratome(R), Acta Ophthalmol., 95, e160, 10.1111/aos.13211 Schaub, 2017, One-year outcome after Descemet membrane endothelial keratoplasty (DMEK) comparing sulfur hexafluoride (SF6) 20% versus 100% air for anterior chamber tamponade, Br. J. Ophthalmol., 101, 902, 10.1136/bjophthalmol-2016-309653 Schaub, 2017, [Deep anterior lamellar keratoplasty : experiences and results of the first 100 consecutive DALK from the university eye hospital of Cologne], Ophthalmologe : Z. Dtsch. Ophthalmol. Ges., 114, 1019, 10.1007/s00347-016-0424-4 Schaub, 2018, [Boston keratoprosthesis: 73 eyes from Germany : an overview of experiences from two centers], Ophthalmologe : Z. Dtsch. Ophthalmol. Ges., 115, 744, 10.1007/s00347-017-0581-0 Schlotzer-Schrehardt, 2015, Ultrastructure of the posterior corneal stroma, Ophthalmology, 122, 693, 10.1016/j.ophtha.2014.09.037 Scholler, 2002, Cutting edge: CD83 regulates the development of cellular immunity, J. Immunol., 168, 2599, 10.4049/jimmunol.168.6.2599 Schrittenlocher, 2019, Impact of preoperative visual acuity on Descemet Membrane Endothelial Keratoplasty (DMEK) outcome. Graefe's archive for clinical and experimental ophthalmology, Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol., 257, 321, 10.1007/s00417-018-4193-4 Schrittenlocher, 2017, Intraocular lens calcifications after (triple-) Descemet membrane endothelial keratoplasty, Am. J. Ophthalmol., 179, 129, 10.1016/j.ajo.2017.04.024 Schrittenlocher, 2018, Evolution of consecutive Descemet membrane endothelial keratoplasty outcomes throughout a 5-Year period performed by two experienced surgeons, Am. J. Ophthalmol., 190, 171, 10.1016/j.ajo.2018.03.036 Seitz, 1999, Nonmechanical corneal trephination with the excimer laser improves outcome after penetrating keratoplasty, Ophthalmology, 106, 1156, 10.1016/S0161-6420(99)90265-8 Seo, 2015, MicroRNA miR-466 inhibits Lymphangiogenesis by targeting prospero-related homeobox 1 in the alkali burn corneal injury model, J. Biomed. Sci., 22, 3, 10.1186/s12929-014-0104-0 Sepsakos, 2016 Sheldon, 2006, HLA typing and its influence on organ transplantation, Methods Mol. Biol., 333, 157 Shimazaki, 2011, Prospective, randomized study of the efficacy of systemic cyclosporine in high-risk corneal transplantation, Am. J. Ophthalmol., 152, 33, 10.1016/j.ajo.2011.01.019 Shortt, 2014, Three-year outcomes of cultured limbal epithelial allografts in aniridia and Stevens-Johnson syndrome evaluated using the Clinical Outcome Assessment in Surgical Trials assessment tool, Stem Cell. Transl. Med., 3, 265, 10.5966/sctm.2013-0025 Siebelmann, 2016, [Intraoperative optical coherence tomography in deep anterior lamellar keratoplasty], Klin. Monatsblatter Augenheilkd., 233, 717 Singh, 2017, Systematic review and meta-analysis of clinical outcomes of descemet membrane endothelial keratoplasty versus descemet stripping endothelial keratoplasty/descemet stripping automated endothelial keratoplasty, Cornea, 36, 1437, 10.1097/ICO.0000000000001320 Singh, 2013, Soluble vascular endothelial growth factor receptor 3 is essential for corneal alymphaticity, Blood, 121, 4242, 10.1182/blood-2012-08-453043 Sloper, 2001, Tacrolimus (FK506) in the management of high-risk corneal and limbal grafts, Ophthalmology, 108, 1838, 10.1016/S0161-6420(01)00759-X Sogutlu Sari, 2012, Penetrating keratoplasty versus deep anterior lamellar keratoplasty: comparison of optical and visual quality outcomes, Br. J. Ophthalmol., 96, 1063, 10.1136/bjophthalmol-2011-301349 Soh, 2017, Translational issues for human corneal endothelial tissue engineering, J. Tissue Eng. Regenerat. Med., 11, 2425, 10.1002/term.2131 Soma, 2014, Maintenance and distribution of epithelial stem/progenitor cells after corneal reconstruction using oral mucosal epithelial cell sheets, PLoS One, 9, 10.1371/journal.pone.0110987 Song, 2018, Mesenchymal stromal cells inhibit inflammatory lymphangiogenesis in the cornea by suppressing macrophage in a TSG-6-dependent manner, Mol. Ther. : J. Am. Soc. Gene Ther., 26, 162, 10.1016/j.ymthe.2017.09.026 Sonoda, 1992, Orthotopic corneal transplantation in mice--evidence that the immunogenetic rules of rejection do not apply, Transplantation, 54, 694, 10.1097/00007890-199210000-00026 Spiteri, 2015, Corneal angiography for guiding and evaluating fine-needle diathermy treatment of corneal neovascularization, Ophthalmology, 122, 1079, 10.1016/j.ophtha.2015.02.012 Spoerl, 2007, Safety of UVA-riboflavin cross-linking of the cornea, Cornea, 26, 385, 10.1097/ICO.0b013e3180334f78 Stern, 2005, Role of interferon-gamma in a mouse model of allergic conjunctivitis, Investig. Ophthalmol. Vis. Sci., 46, 3239, 10.1167/iovs.05-0138 Steven, 2011, Intravital two-photon microscopy of immune cell dynamics in corneal lymphatic vessels, PLoS One, 6, 10.1371/journal.pone.0026253 Stoitzner, 2003, Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against Langerin/CD207, J. Investig. Dermatol., 120, 266, 10.1046/j.1523-1747.2003.12042.x Stoitzner, 2002, A close-up view of migrating Langerhans cells in the skin, J. Investig. Dermatol., 118, 117, 10.1046/j.0022-202x.2001.01631.x Streilein, 1993, Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments, Curr. Opin. Immunol., 5, 428, 10.1016/0952-7915(93)90064-Y Streilein, 1999, Regional immunity and ocular immune privilege, Chem. Immunol., 73, 11, 10.1159/000058741 Streilein, 2003, Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation, J. Leukoc. Biol., 74, 179, 10.1189/jlb.1102574 Streilein, 1980, Systemic immune unresponsiveness induced in adult mice by anterior chamber presentation of minor histocompatibility antigens, J. Exp. Med., 152, 1121, 10.1084/jem.152.4.1121 Streilein, 2000, Does innate immune privilege exist?, J. Leukoc. Biol., 67, 479, 10.1002/jlb.67.4.479 Streilein, 1992, Immunoregulatory mechanisms of the eye, J. Neuroimmunol., 39, 185, 10.1016/0165-5728(92)90253-H Stuart, 2018, Descemet's membrane endothelial keratoplasty (DMEK) versus Descemet's stripping automated endothelial keratoplasty (DSAEK) for corneal endothelial failure, Cochrane Database Syst. Rev., 6, CD012097 Stuart, 1997, CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival, J. Clin. Investig., 99, 396, 10.1172/JCI119173 Su, 2015, Phenotypes of trypsin- and collagenase-prepared bovine corneal endothelial cells in the presence of a selective Rho kinase inhibitor, Y-27632, Mol. Vis., 21, 633 Sugino, 2011, A method to enhance cell survival on Bruch's membrane in eyes affected by age and age-related macular degeneration, Investig. Ophthalmol. Vis. Sci., 52, 9598, 10.1167/iovs.11-8400 Suh, 2008, Complications of Descemet's stripping with automated endothelial keratoplasty: survey of 118 eyes at One Institute, Ophthalmology, 115, 1517, 10.1016/j.ophtha.2008.01.024 Sumioka, 2008, Inhibitory effect of blocking TGF-beta/Smad signal on injury-induced fibrosis of corneal endothelium, Mol. Vis., 14, 2272 Sun, 2017, Sema3f protects against subretinal neovascularization in vivo, EBioMedicine, 18, 281, 10.1016/j.ebiom.2017.03.026 Szaflik, 2016, Systemic immunosuppression with mycophenolate mofetil to prevent corneal graft rejection after high-risk penetrating keratoplasty: a 2-year follow-up study, Graefe's Arch. Clin. Exp. Ophthalmol. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol., 254, 307, 10.1007/s00417-015-3200-2 Tammela, 2005, Angiopoietin-1 promotes lymphatic sprouting and hyperplasia, Blood, 105, 4642, 10.1182/blood-2004-08-3327 Tandon, 2010, Role of transforming growth factor Beta in corneal function, biology and pathology, Curr. Mol. Med., 10, 565 Taylor, 1999, Ocular immunosuppressive microenvironment, Chem. Immunol., 73, 72, 10.1159/000058738 Thatte, 2011, Fine needle diathermy - a choice for managing corneal vascularization, Nepal. J. Ophthalmol. : A Biannu. Peer-Reviewed Acad. J. Nepal Ophthalmic Soc., 3, 23, 10.3126/nepjoph.v3i1.4274 Thorne, 2005, Mycophenolate mofetil therapy for inflammatory eye disease, Ophthalmology, 112, 1472, 10.1016/j.ophtha.2005.02.020 Torres, 1996, Cytokine mRNA expression during experimental corneal allograft rejection, Exp. Eye Res., 63, 453, 10.1006/exer.1996.0135 Toth, 2016, In situ corneal cross-linking for recurrent corneal melting after Boston type 1 keratoprosthesis, Cornea, 35, 884, 10.1097/ICO.0000000000000830 Tourtas, 2012, Descemet membrane endothelial keratoplasty versus descemet stripping automated endothelial keratoplasty, Am. J. Ophthalmol., 153, 1082, 10.1016/j.ajo.2011.12.012 Tu, 2017, Descemet membrane endothelial keratoplasty patch for persistent corneal hydrops, Cornea, 36, 1559, 10.1097/ICO.0000000000001351 Twist, 1998, The mouse Cd83 gene: structure, domain organization, and chromosome localization, Immunogenetics, 48, 383, 10.1007/s002510050449 Unal, 2013, Deep anterior lamellar keratoplasty for the treatment of stromal corneal dystrophies, Cornea, 32, 301, 10.1097/ICO.0b013e31825718ca van Essen, 2015, Matching for Human Leukocyte Antigens (HLA) in corneal transplantation - to do or not to do, Prog. Retin. Eye Res., 46, 84, 10.1016/j.preteyeres.2015.01.001 Veikkola, 1999, VEGFs, receptors and angiogenesis, Semin. Canc. Biol., 9, 211, 10.1006/scbi.1998.0091 Verteporfin in Photodynamic Therapy Study Group, 2001, Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1, Ophthalmology, 108, 841, 10.1016/S0161-6420(01)00544-9 Wacker, 2016, Descemet stripping endothelial keratoplasty for Fuchs' endothelial corneal dystrophy: five-year results of a prospective study, Ophthalmology, 123, 154, 10.1016/j.ophtha.2015.09.023 Watanabe, 2004, Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis, J. Clin. Investig., 114, 898, 10.1172/JCI200421152 Weiss, 2012, Angiogenesis inhibition for the improvement of photodynamic therapy: the revival of a promising idea, Biochim. Biophys. Acta, 1826, 53 Wenkel, 2000, Evidence that retinal pigment epithelium functions as an immune-privileged tissue, Investig. Ophthalmol. Vis. Sci., 41, 3467 Wielders, 2017, Treatment of cystoid macular edema after cataract surgery, J. Cataract Refract. Surg., 43, 276, 10.1016/j.jcrs.2016.06.041 Wigle, 2002, An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype, EMBO J., 21, 1505, 10.1093/emboj/21.7.1505 Williams, 2006, How effective is penetrating corneal transplantation? Factors influencing long-term outcome in multivariate analysis, Transplantation, 81, 896, 10.1097/01.tp.0000185197.37824.35 Williams, 2015 Willrodt, 2019, ALCAM mediates DC migration through afferent lymphatics and promotes allospecific immune reactions, Front. Immunol., 10, 759, 10.3389/fimmu.2019.00759 Wollensak, 2004, Keratocyte cytotoxicity of riboflavin/UVA-treatment in vitro, Eye, 18, 718, 10.1038/sj.eye.6700751 Wollensak, 2003, Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus, Am. J. Ophthalmol., 135, 620, 10.1016/S0002-9394(02)02220-1 Wollensak, 2004, Keratocyte apoptosis after corneal collagen cross-linking using riboflavin/UVA treatment, Cornea, 23, 43, 10.1097/00003226-200401000-00008 Wong, 2012, When MT1-MMP meets ADAMs, Cell Cycle, 11, 2793, 10.4161/cc.20949 Wong, 2016, MT1-MMP sheds LYVE-1 on lymphatic endothelial cells and suppresses VEGF-C production to inhibit lymphangiogenesis, Nat. Commun., 7, 10824, 10.1038/ncomms10824 Wu, 2012, Graft rejection following descemet stripping automated endothelial keratoplasty: features, risk factors, and outcomes, Am. J. Ophthalmol., 153, 949, 10.1016/j.ajo.2011.10.004 Xiao, 2015, Minor type IV collagen alpha5 chain promotes cancer progression through discoidin domain receptor-1, PLoS Genet., 11, 10.1371/journal.pgen.1005249 Yagi-Yaguchi, 2017, Preoperative aqueous cytokine levels are associated with a rapid reduction in endothelial cells after penetrating keratoplasty, Am. J. Ophthalmol., 181, 166, 10.1016/j.ajo.2017.07.005 Yamada, 2016, Allogeneic sensitization and tolerance induction after corneal endothelial cell transplantation in mice, Investig. Ophthalmol. Vis. Sci., 57, 4572, 10.1167/iovs.15-19020 Yamagami, 2003, Role of resident corneal leukocytes and draining cervical lymph nodes in corneal allograft rejection, Cornea, 22, S61, 10.1097/00003226-200310001-00009 Yamaguchi, 2016, Optimization of cultured human corneal endothelial cell sheet transplantation and post-operative sheet evaluation in a rabbit model, Curr. Eye Res., 41, 1178, 10.3109/02713683.2015.1101774 Yamaguchi, 2018, Elevation of preoperative recipient aqueous cytokine levels in eyes with primary graft failure after corneal transplantation, Mol. Vis., 24, 613 Yamazoe, 2014, Efficacy and safety of systemic tacrolimus in high-risk penetrating keratoplasty after graft failure with systemic cyclosporine, Cornea, 33, 1157, 10.1097/ICO.0000000000000258 Yazu, 2018, Preoperative aqueous cytokine levels are associated with endothelial cell loss after descemet's stripping automated endothelial keratoplasty, Investig. Ophthalmol. Vis. Sci., 59, 612, 10.1167/iovs.17-23049 Yoon, 2006, Experimental inhibition of corneal neovascularization by photodynamic therapy with verteporfin, Curr. Eye Res., 31, 215, 10.1080/02713680600559564 Yoshida, 2000, Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 2. Generation of TGF-beta-producing regulatory T cells, Investig. Ophthalmol. Vis. Sci., 41, 3862 Yoshida, 2000, Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact, Investig. Ophthalmol. Vis. Sci., 41, 811 Yu, 2011, Progenitors for the corneal endothelium and trabecular meshwork: a potential source for personalized stem cell therapy in corneal endothelial diseases and glaucoma, J. Biomed. Biotechnol., 2011, 412743, 10.1155/2011/412743 Yuen, 2014, Role of angiopoietin-2 in corneal lymphangiogenesis, Investig. Ophthalmol. Vis. Sci., 55, 3320, 10.1167/iovs.13-13779 Zhai, 2011, Tacrolimus in the treatment of ocular diseases, BioDrugs : Clin. Immunother. Biopharm. Gene Ther., 25, 89, 10.2165/11587010-000000000-00000 Zheng, 2011, Clinicopathological correlation analysis of (lymph) angiogenesis and corneal graft rejection, Mol. Vis., 17, 1694 Zhou, 2000, Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I, Proc. Natl. Acad. Sci. U. S. A, 97, 4052, 10.1073/pnas.060037197 Zhu, 2014, Activation of RhoA-ROCK-BMP signaling reprograms adult human corneal endothelial cells, J. Cell Biol., 206, 799, 10.1083/jcb.201404032 Ziaei, 2016, Systemic cyclosporine and corneal transplantation, Int. Ophthalmol., 36, 139, 10.1007/s10792-015-0137-8 Ziemssen, 2012, Evaluation of verteporfin pharmakokinetics--redefining the need of photosensitizers in ophthalmology, Expert Opin. Drug Metabol. Toxicol., 8, 1023, 10.1517/17425255.2012.701617 Zirm, 1906, Eine erfolgreiche totale Keratoplastik, Albr. Graefe's Arch. Ophthalmol., 64, 580, 10.1007/BF01949227 Zygoura, 2018, Quarter-Descemet membrane endothelial keratoplasty (Quarter-DMEK) for Fuchs endothelial corneal dystrophy: 6 months clinical outcome, Br. J. Ophthalmol., 102, 1425, 10.1136/bjophthalmol-2017-311398